CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD

 CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD

Drug Candidate, CQ-001 (cannabidiol “CBD” + IP formula), also demonstrated substantially reduced seizures at higher doses, with less CBD, compared to standard CBD.
TORONTO, ON / ACCESSWIRE / Decembe…